Skip to Main Content
Table I.

Multilineage analysisa

nb% DonorPercentage in Donor (H2Kd+) Lymphoid Gatec
αβ-TCRCD8CD4B220DX5Mac-1Gr-1CD11c
Ad 11 99.7 ± 0.5 20.0 ± 5.5 2.5 ± 0.9 17.6 ± 5.7 73.7 ± 5.2 6.3 ± 5.0 2.2 ± 0.5 1.0 ± 0.3 1.1 ± 0.1 
Be 10 15.6 ± 8.9 13.9 ± 6.2 1.8 ± 1.1 11.9 ± 5.8 80.2 ± 5.9 0.7 ± 0.2 2.7 ± 0.8 N/A 0.6 ± 0 
nb% DonorPercentage in Donor (H2Kd+) Lymphoid Gatec
αβ-TCRCD8CD4B220DX5Mac-1Gr-1CD11c
Ad 11 99.7 ± 0.5 20.0 ± 5.5 2.5 ± 0.9 17.6 ± 5.7 73.7 ± 5.2 6.3 ± 5.0 2.2 ± 0.5 1.0 ± 0.3 1.1 ± 0.1 
Be 10 15.6 ± 8.9 13.9 ± 6.2 1.8 ± 1.1 11.9 ± 5.8 80.2 ± 5.9 0.7 ± 0.2 2.7 ± 0.8 N/A 0.6 ± 0 
a

Multilineage typing was performed in mice between 2 and 3 mo after second BMT.

b

Mice were conditioned with anti-CD154 alone or combined with anti-αβ-TCR at the primary BMT.

c

Mean ± SD percentage of donor cells in donor lymphoid gate.

d

A, Myeloablative conditioning at secondary BMT.

e

B, Nonmyeloablative conditioning at secondary BMT.

Close Modal

or Create an Account

Close Modal
Close Modal